In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.
about
Comparative in vitro activity of WIN 57273, a new fluoroquinolone antimicrobial agentTrovafloxacin is active against Toxoplasma gondiiSusceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents.Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates.In vitro antibacterial activity of Q-35, a new fluoroquinoloneInhibition by quinolones of DNA gyrase from Staphylococcus aureus.In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin.In vitro activity of tosufloxacin, a new quinolone, against respiratory pathogens derived from cystic fibrosis sputum.In vitro activity of tosufloxacin (A-61827; T-3262) against selected genital pathogensAntibacterial activity of NM394, the active form of prodrug NM441, a new quinolone.In vitro and in vivo antibacterial activities of CS-940, a new fluoroquinolone, against isolates from patients with respiratory infections.In vitro activities of tosufloxacin, temafloxacin, and A-56620 against pathogens of diarrhea.In vitro and in vivo activities of a new quinolone, WIN 57273, possessing potent activity against gram-positive bacteria.In vitro susceptibilities of Pseudomonas pseudomallei to 27 antimicrobial agents.In vitro and in vivo antibacterial activities of T-3761, a new quinolone derivative.In vitro and in vivo antibacterial activities of a new quinolone, OPC-17116.Antimicrobial activity of DV-7751a, a new fluoroquinoloneReduced susceptibilities of Shigella sonnei strains isolated from patients with dysentery to fluoroquinolones.Newly documented antimicrobial activity of quinolones.New quinolone antibiotics: a survey of the literature from 2005 to 2010.Therapy of enterococcal infections.Developments in quinolones. Bacteriology, pharmacokinetics and initial clinical experience of several investigational quinolone derivatives.Improved bactericidal activity of Q-35 against quinolone-resistant staphylococci.In vitro antibacterial activity of DU-6859a, a new fluoroquinolone.Antibacterial activity and pharmacokinetics of four new 7-azetidinyl fluoroquinolonesIn vitro and in vivo antibacterial activities of CS-940, a new 6-fluoro-8-difluoromethoxy quinoloneIn vitro activity of HSR-903, a new quinolone.Intracellular activity of tosufloxacin (T-3262) against Salmonella enteritidis and ability to penetrate into tissue culture cells of human origin.Quinolone resistance in clinical isolates of Serratia marcescensCloning and expression of the norA gene for fluoroquinolone resistance in Staphylococcus aureus.Inhibitory effects of quinolones on DNA gyrase of Escherichia coli and topoisomerase II of fetal calf thymus.Emergence of fluoroquinolone resistance in Bacteroides fragilis accompanied by resistance to beta-lactam antibiotics.Activity of KB-5246 against outer membrane mutants of Escherichia coli and Salmonella typhimurium.In vitro antibacterial activities of tosufloxacin against and uptake of tosufloxacin by outer membrane mutants of Escherichia coli, Proteus mirabilis, and Salmonella typhimurium.In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone.Mechanisms of high-level resistance to quinolones in urinary tract isolates of Pseudomonas aeruginosa.In vitro activity of tosufloxacin (A-60969) and clarithromycin (A-56268, TE-031) against resistant Haemophilus influenzae, Streptococcus pneumoniae and Branhamella catarrhalis isolates.Value of new quinolones in the treatment and prophylaxis of infectious diseases: introductory remarks.
P2860
Q28335923-A92ED395-94EB-4C09-81CC-6BD17A798CF1Q28379193-4E9BA5F8-11D0-43A7-B2D3-FC56C708292CQ33744238-8A92C886-3CF2-4236-B98C-896FE1CC8457Q34537808-DE7611B5-BCBC-4E7A-9967-26300B2959E9Q34537973-1C1CEAA1-977E-4A17-AFDA-F9DC99ADE9D5Q34566027-0833E048-ACD6-4A87-9C42-0115F8FBB093Q34601561-DF942AA3-0D1A-4EE4-9929-4B9DFCD112DDQ34622742-D35A2D70-0D49-4397-AA49-B72718E15404Q34626011-F16DE7F9-8604-4F4F-88C8-197DB62CC4A5Q34729788-D2ADCDF6-8F0C-49F6-9C93-C964418C5A0FQ35139147-14D9D6E5-A16F-408E-968C-D06FDE147549Q35249168-36DC9E5F-C8FB-4DDA-9828-327C4AB98C32Q35251994-19D5E070-AA06-4A93-9792-F746103628DEQ35278735-AC52AEE4-7B62-4218-971E-32719C9C4AC4Q35809707-8DE3C281-E8E7-4092-B8C7-98BE6EEEA54CQ35867101-D120C90A-DAB7-426E-AD0F-229E98C0ED72Q35897320-5C06F2B7-7253-4796-BA38-AC99C5682768Q35900349-EA74AC02-BD46-4315-9635-CA162520F2ACQ37222571-C88D6031-2197-476D-A50F-D58F64DAE789Q37774376-D3E7BA9F-B0A4-4B89-8929-D22CDE761A34Q37909576-9B471FA8-0066-404F-9A5D-99F41E034C60Q38635746-84FBAA2D-0127-4FE3-93C0-DC70E246FF48Q39780025-3ADC6195-7667-45E9-8D6A-794279C4F15EQ39781097-E8EF9B3C-0421-4295-A300-2457366FFC0EQ39781332-317F274F-20CC-48F5-90A6-78EEC18F9FCBQ39782054-E7F65536-EC17-45A1-8CFD-6CFDA4FA2033Q39784355-0B4D49AE-DDA6-4DDA-9F1A-43D21F64E58DQ39816058-08C61255-1A0B-47B6-8D52-32BAC74F85F4Q39819300-DAB3D5F1-FBAD-4B9C-B36C-457A9B41BCC0Q39819907-C1138BA2-7A17-4B36-80E1-625C87DB83B4Q39820165-37FCB767-3830-42F9-A893-E2D52AE781A2Q39832372-0A8D3FA2-F61E-49B2-9CA0-7A31467AFB29Q39832736-81446BBA-4CE3-463B-A899-99E9BB40D0AEQ39882625-566F8743-A445-41A3-9C97-25B44B632427Q40285332-658EF064-7064-4480-A6B0-5DA9795E5CFFQ40285759-CAEF3B81-B738-4FAA-8F0C-44B97CEFFA55Q45269526-93EEF987-2123-4312-BF72-94057DC05D33Q54722061-E44253EA-9D05-44EE-A846-43CFECAD8EC3
P2860
In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.
description
1988 nî lūn-bûn
@nan
1988 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.
@ast
In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.
@en
In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.
@nl
type
label
In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.
@ast
In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.
@en
In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.
@nl
prefLabel
In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.
@ast
In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.
@en
In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.
@nl
P2093
P2860
P356
P1476
In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.
@en
P2093
P2860
P304
P356
10.1128/AAC.32.6.827
P407
P577
1988-06-01T00:00:00Z